XML 36 R28.htm IDEA: XBRL DOCUMENT v3.19.3

NOTE 7 – INTANGIBLE ASSETS (Tables)

9 Months Ended

Sep. 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

The following table sets forth the gross carrying amount, accumulated amortization and net carrying amount of our intangible assets as of September 30, 2019 and December 31, 2018:

The following table sets forth the gross carrying amount, accumulated amortization and net carrying amount of our intangible assets as of September 30, 2019 and December 31, 2018:

		September 30, 2019
		Gross Carrying Amount				Accumulated Amortization				Net Amount				Weighted-Average Remaining Amortization Period (yrs.)
Amortizable intangible assets:
Approved hormone therapy drug candidate patents			3,138,308				(421,694	)			2,716,614				13.25 years
Hormone therapy drug candidate patent (pending)			1,937,691				—				1,937,691				n/a
Non-amortizable intangible assets:
Multiple trademarks			287,846				—				287,846				indefinite
TOTAL		$	5,363,845			$	(421,694	)		$	4,942,151
		December 31, 2018
		Gross Carrying Amount				Accumulated Amortization				Net Amount				Weighted-Average Remaining Amortization Period (yrs.)
Amortizable intangible assets:
OPERA® software patent		$	31,951			$	(10,484	)		$	21,467				10.75 years
Development costs of corporate website			91,743				(91,743	)			—				n/a
Approved hormone therapy drug candidate patents			2,234,129				(282,485	)			1,951,644				14 years
Hormone therapy drug candidate patents (pending)			1,855,279				—				1,855,279				n/a
Non-amortizable intangible assets:
Multiple trademarks			264,289				—				264,289				indefinite
TOTAL		$	4,477,391			$	(384,712	)		$	4,092,679

Estimated amortization expense for the next five years for the patent costs currently being amortized is as follows:

Estimated amortization expense for the next five years for the patent costs currently being amortized is as follows:

Year Ending December 31,				Estimated Amortization
	2019 (3 months)			$	51,259
	2020			$	205,035
	2021			$	205,035
	2022			$	205,035
	2023			$	205,035

X

- Definition

Tabular disclosure of intangible assets, which may be broken down by major class.

+ References

No definition available.

+ Details

Name:	txmd_ScheduleOfIntangibleAssetsTableTextBlock
Namespace Prefix:	txmd_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

+ Details

Name:	us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration